Fate Therapeutics Inc. – Filings and Transcripts

NASDAQ: FATE
Share price (5/22/26): $2.25
Market cap (5/22/26): $262 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Prospectus supplement

Shelf registration

Ownership Filter

Valamehr Bahram

Valamehr Bahram

News Filter

Reports First Quarter 2026 Financial Results and Business Updates

Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Reports Third Quarter 2025 Financial Results and Business Updates

Presents New Clinical Data at ACR Convergence 2025 Demonstrating Immune Remodeling and Durable Responses in Patients With Systemic Lupus Erythematosus Treated With FT819 Off-The-Shelf CAR T-Cell Therapy

Expands Leadership Team With Appointment of Kamal Adawi as Chief Financial Officer

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Scanned paper annual report submission

Correspondence with the SEC